$10.18
-0.34-3.23%
At close: -
$10.18
0.000.00%
After Hours: Mar 7, 4:00 PM EDT
Comments
Loading...
Myriad Genetics Stock Guidance | NASDAQ:MYGN | Benzinga
Myriad Genetics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Myriad Genetics (MYGN)?
The most recent guidance for Myriad Genetics (MYGN) was reported on February 24, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $0.07 to $0.11, compared to the estimated EPS of $0.06. Additionally, Myriad Genetics forecasted revenue between $0.84B and $0.86B for the quarter.
Browse guidance and forecast on all stocks.